LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 146 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $72,000 | -89.7% | 15,700 | -86.8% | 0.00% | -100.0% |
| Q1 2021 | $697,000 | -0.4% | 118,800 | -42.0% | 0.00% | 0.0% |
| Q4 2020 | $700,000 | +55.2% | 204,900 | -34.6% | 0.00% | +50.0% |
| Q3 2020 | $451,000 | -3.0% | 313,300 | +34.3% | 0.00% | 0.0% |
| Q2 2020 | $465,000 | +46.7% | 233,200 | +43.2% | 0.00% | 0.0% |
| Q1 2020 | $317,000 | -40.6% | 162,800 | +26.3% | 0.00% | 0.0% |
| Q4 2019 | $534,000 | – | 128,900 | – | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $697,000 | -10.6% | 50,400 | +16.7% | 0.00% | 0.0% |
| Q3 2016 | $780,000 | -0.5% | 43,200 | -21.0% | 0.00% | 0.0% |
| Q2 2016 | $784,000 | +13.0% | 54,700 | -5.9% | 0.00% | 0.0% |
| Q1 2016 | $694,000 | +17250.0% | 58,100 | +16220.2% | 0.00% | – |
| Q4 2015 | $4,000 | +33.3% | 356 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | +50.0% | 356 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | – | 356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |